-
1
OmniVu Lens System shows promising 36-month data.
-
2
Reported stable refractive outcomes within ±0.50 D.
-
3
Mean binocular uncorrected distance visual acuity at 20/
-
4
Innovative two-part modular design for better accommodation.
-
5
Only one YAG capsulotomy reported during the study.
-
6
Early contrast sensitivity comparable to monofocal IOLs.
-
7
Has FDA IDE approval for US feasibility study.
Original Source(s)
Related Content
Inside the Aging Eye
A comprehensive new Elsevier publication brings global expertise together to unpack how aging drives ocular structure, function, and disease
April 28, 2026
-
2 min
Keeping an Eye on Diabetes
Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program
April 28, 2026
-
7 min
Seeing the Halo
Researchers evaluate a novel optical phenomenon that could expand the clinical value of slit-lamp examination in keratoconus
April 27, 2026
-
3 min
